A detailed history of Gsa Capital Partners LLP transactions in Pfizer Inc stock. As of the latest transaction made, Gsa Capital Partners LLP holds 32,786 shares of PFE stock, worth $860,304. This represents 0.07% of its overall portfolio holdings.

Number of Shares
32,786
Previous 17,476 87.61%
Holding current value
$860,304
Previous $489,000 94.07%
% of portfolio
0.07%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$27.7 - $31.39 $424,087 - $480,580
15,310 Added 87.61%
32,786 $949,000
Q2 2024

Aug 15, 2024

BUY
$25.26 - $29.6 $41,679 - $48,840
1,650 Added 10.43%
17,476 $489,000
Q1 2024

May 03, 2024

BUY
$25.89 - $29.73 $409,735 - $470,506
15,826 New
15,826 $439,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $293,717 - $358,555
6,712 New
6,712 $294,000
Q2 2022

Aug 09, 2022

SELL
$46.53 - $55.17 $1.19 Million - $1.41 Million
-25,510 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $997,624 - $1.24 Million
21,806 Added 588.71%
25,510 $1.32 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $334,939 - $496,492
-8,106 Reduced 68.64%
3,704 $219,000
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $463,542 - $595,460
11,810 New
11,810 $508,000
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $276,526 - $311,866
-8,257 Closed
0 $0
Q4 2020

Feb 03, 2021

BUY
$33.47 - $42.56 $276,361 - $351,417
8,257 New
8,257 $304,000
Q1 2020

May 12, 2020

SELL
$27.03 - $38.62 $183,804 - $262,616
-6,800 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$32.92 - $37.36 $203,182 - $230,585
-6,172 Reduced 47.58%
6,800 $266,000
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $421,460 - $546,510
12,972 New
12,972 $466,000
Q2 2019

Aug 06, 2019

SELL
$36.98 - $41.52 $621,264 - $697,536
-16,800 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $370,875 - $407,468
-9,890 Reduced 37.06%
16,800 $713,000
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $51,318 - $58,509
-1,334 Reduced 4.76%
26,690 $1.17 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $624,148 - $757,053
18,107 Added 182.59%
28,024 $1.24 Million
Q2 2018

Aug 09, 2018

BUY
$32.98 - $35.16 $327,062 - $348,681
9,917 New
9,917 $360,000
Q1 2018

May 11, 2018

SELL
$31.91 - $37.02 $1.87 Million - $2.17 Million
-58,604 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $1.95 Million - $2.07 Million
58,604
58,604 $2.12 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.